Search peptide products and verified companies

Long-acting amylin analogue

Cagrilintide

Also called AM833

Human-use stop

Cagrilintide has no authorised public-use medicine in UK + USA. Do not treat a research listing as a care route.

A research-only label, professional website, company registration or COA cannot turn it into an approved medicine.

UKTrial only

Clinical-trial access only

No authorised public-use cagrilintide medicine is identified in the UK.

USATrial only

Clinical-trial access only

No FDA-approved public-use cagrilintide medicine is identified.

A. Product statusClinical-trial access onlyTap for details

UK: Clinical-trial access only. No authorised public-use cagrilintide medicine is identified in the UK. USA: Clinical-trial access only. No FDA-approved public-use cagrilintide medicine is identified.

B. Company and legal routeNo seller can turn this into an approved human-use routeTap for details

A real company, professional website, research-only disclaimer or laboratory report cannot override Gate A.

C. Exact purchaseDo not buy this for human self-useTap for details

A batch report cannot make an investigational, warned or unapproved product an approved consumer medicine.

Research evidence context: Human studies are present. Research evidence level B. A human study does not by itself establish approval, effectiveness or a safe buying route; animal and in-vitro findings are kept separate.

Market surveillance: sites listing Cagrilintide21 not recommendations

These records help identify risky listings. They are deliberately unranked and are not places PepCred recommends buying from.

Ascension PeptidesUK